BeStock  
Stocks › Biotechnology › SYRE

Spyre Therapeutics SYRE

US equityMarket cap rank #1512Biotechnology
$93.47 −$4.16 (-4.26%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $93.47 0.00%
Open$95.93
Prev close$97.63
Day range$93.22 – $99.56
Volume805.4K
Market cap$8.88B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership106.9%-3.41 pts vs. prior quarter
Institutions holding365+34 vs. prior quarter
Insider trades (recent)13 buys / 37 sellsNet selling
Short interest12.60% of floatDays to cover 12.7 · as of 30 Oct 2026
Short-sale volume share23.7%5-day average of daily volume

Short-sale volume as % of daily volume

14%22%30%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$15.61M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$15.0MSuper−$621.1KBig−$200.6KMid−$12.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.1% of shares outstanding.

Largest holders

  • FMR14.21%
  • BlackRock7.14%
  • Paradigm Biocapital Advisors LP4.69%
  • Perceptive Advisors LLC4.55%
  • RTW Investments, LP4.48%
  • Vanguard Portfolio Management, LLC4.28%
  • Vanguard Capital Management, LLC3.95%
  • Peter Deutsch3.74%

By investor type

  • Mutual Fund71.02%
  • Hedge Fund20.48%
  • VC/PE Fund10.81%
  • Individual/Insider5.29%
  • Public Company3.45%
  • Private Company0.50%
  • Government Pension Fund0.29%
  • Insurance Company0.25%

Reported short interest has fallen from 13.33% to 12.60% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
ClearBridge Investments, LLC Mutual Fund 2026/Q3 +238,480 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,733,691 4.3%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +599,224 0.6%
State Street Global Advisors Mutual Fund 2026/Q3 +476,446 3.7%
FMR Mutual Fund 2026/Q3 +470,409 14.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +302,112 3.9%
BlackRock Mutual Fund 2026/Q3 +272,881 7.1%
Fiera Capital Corporation Mutual Fund 2026/Q3 +255,104 0.3%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +616,672 4.7%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,744,968 2.6%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +1,722,300 1.8%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,362,125 3.1%
FMR Mutual Fund 2026/Q3 +1,245,163 14.8%
Holocene Advisors, LP Hedge Fund 2026/Q3 +1,015,170 1.1%
BlackRock Mutual Fund 2026/Q3 +985,384 7.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Cameron Turtle Chief Executive Officer Automatic Disposition -15,000 $93.91 537,540
30 Sep 2026 Heidy King-Jones Chief Legal Officer Derivative Exercise and Sale -28,933 $93.46 2,845
30 Sep 2026 Scott Burrows Chief Financial Officer Derivative Exercise and Sale -25,000 $93.57 46,024
29 Sep 2026 Scott Burrows Chief Financial Officer Intent to Sell (Form 144) -17,500 $89.89 –
1 Sep 2026 Scott Burrows Chief Financial Officer Open Market Disposition -18,232 $89.35 46,024
1 Sep 2026 Heidy King-Jones Chief Legal Officer Derivative Exercise and Sale -28,399 $90.00 2,845
31 Aug 2026 Cameron Turtle Chief Executive Officer Automatic Disposition -15,000 $89.07 552,540
31 Aug 2026 Heidy King-Jones Chief Legal Officer Intent to Sell (Form 144) -46,665 $89.33 –
31 Aug 2026 Scott Burrows Chief Financial Officer Derivative Exercise and Sale -7,500 $89.04 46,024
6 Aug 2026 Jeffrey Albers Independent Chairperson Automatic Disposition -18,000 $104.68 9,360
6 Aug 2026 Jeffrey Albers Independent Chairperson Derivative Exercise and Sale -5,000 $104.47 9,360
2 Aug 2026 Cameron Turtle Chief Executive Officer Automatic Disposition -15,000 $97.46 567,540
2 Aug 2026 Scott Burrows Chief Financial Officer Derivative Exercise and Sale -7,500 $97.10 30,518
30 Jun 2026 Cameron Turtle Chief Executive Officer Automatic Disposition -15,000 $88.91 582,540
30 Jun 2026 Scott Burrows Chief Financial Officer Derivative Exercise and Sale -7,500 $88.37 30,518
30 Jun 2026 Sheldon Sloan Chief Medical Officer Derivative Exercise and Sale -8,334 $88.34 –
24 Jun 2026 Scott Burrows Chief Financial Officer Derivative Exercise and Sale -15,000 $87.14 30,518
22 Jun 2026 Fairmount Funds Management LLC Private Disposition -4,018,101 $85.31 –
22 Jun 2026 Fairmount Funds Management LLC Derivative Exercise and Sale -666,680 $85.31 –
21 Jun 2026 Michael Henderson Independent Director Automatic Disposition -20,000 $100.00 68,606

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 11,617,573 12.6% 12.7
15 Oct 2026 12,505,491 13.6% 7.3
30 Sep 2026 12,844,608 14.6% 8.9
15 Sep 2026 12,129,443 13.8% 11.6
31 Aug 2026 11,859,975 13.5% 9.7
14 Aug 2026 11,755,434 13.3% 16.0

Discussion

No comments yet — be the first to weigh in on SYRE.

Sign in to join the discussion.

Scroll to Top